These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 34512721)

  • 21. Small non-coding RNAs as diagnostic, prognostic and predictive biomarkers of gynecological cancers: an update.
    Diamantopoulos MA; Adamopoulos PG; Scorilas A
    Expert Rev Mol Diagn; 2024 Nov; 24(11):979-995. PubMed ID: 39390687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-coding RNA in drug resistance of hepatocellular carcinoma.
    Ding B; Lou W; Xu L; Fan W
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30224380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications.
    Zhou X; Ao X; Jia Z; Li Y; Kuang S; Du C; Zhang J; Wang J; Liu Y
    Front Oncol; 2022; 12():951864. PubMed ID: 36059609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-Coding RNAs Regulate the Resistance to Anti-EGFR Therapy in Colorectal Cancer.
    Chu J; Fang X; Sun Z; Gai L; Dai W; Li H; Yan X; Du J; Zhang L; Zhao L; Xu D; Yan S
    Front Oncol; 2021; 11():801319. PubMed ID: 35111681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Application of Poly(ADP-Ribose) Polymerase Inhibitors in High-Grade Serous Ovarian Cancer.
    Parkes EE; Kennedy RD
    Oncologist; 2016 May; 21(5):586-93. PubMed ID: 27022037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial.
    Oza AM; Cibula D; Benzaquen AO; Poole C; Mathijssen RH; Sonke GS; Colombo N; Špaček J; Vuylsteke P; Hirte H; Mahner S; Plante M; Schmalfeldt B; Mackay H; Rowbottom J; Lowe ES; Dougherty B; Barrett JC; Friedlander M
    Lancet Oncol; 2015 Jan; 16(1):87-97. PubMed ID: 25481791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNAs, long non-coding RNAs, and circular RNAs and gynecological cancers: focus on metastasis.
    Rezaee A; Ahmadpour S; Jafari A; Aghili S; Zadeh SST; Rajabi A; Raisi A; Hamblin MR; Mahjoubin-Tehran M; Derakhshan M
    Front Oncol; 2023; 13():1215194. PubMed ID: 37854681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of Regulation of the Expression of miRNAs and lncRNAs by Metformin in Ovarian Cancer.
    Alfaro I; Vega M; Romero C; Garrido MP
    Pharmaceuticals (Basel); 2023 Oct; 16(11):. PubMed ID: 38004379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
    Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
    Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating non-coding RNAs in recurrent and metastatic ovarian cancer.
    Schwarzenbach H; Gahan PB
    Cancer Drug Resist; 2019; 2(3):399-418. PubMed ID: 35582568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gynecologic cancers and non-coding RNAs: Epigenetic regulators with emerging roles.
    Razavi ZS; Tajiknia V; Majidi S; Ghandali M; Mirzaei HR; Rahimian N; Hamblin MR; Mirzaei H
    Crit Rev Oncol Hematol; 2021 Jan; 157():103192. PubMed ID: 33290823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circular RNAs and their emerging roles as diagnostic and prognostic biomarkers in ovarian cancer.
    Sheng R; Li X; Wang Z; Wang X
    Cancer Lett; 2020 Mar; 473():139-147. PubMed ID: 31904484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-Coding RNAs: Regulating Disease Progression and Therapy Resistance in Hepatocellular Carcinoma.
    Manna D; Sarkar D
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32429062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Regulatory Roles of Long Non-Coding RNA in the Chemoresistance Process of Ovarian cancer.
    Qu J; Kamal MA; Yuan C
    Curr Pharm Des; 2019; 25(8):856-861. PubMed ID: 30947657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Underlying Mechanisms of Noncoding RNAs in the Chemoresistance of Hepatocellular Carcinoma.
    Wang M; Yu F; Chen X; Li P; Wang K
    Mol Ther Nucleic Acids; 2020 Sep; 21():13-27. PubMed ID: 32505000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysregulation of non-coding RNAs in gastric cancer.
    Yang Q; Zhang RW; Sui PC; He HT; Ding L
    World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of Apoptosis-Related Long Non-coding RNAs in Ovarian Cancer.
    Takeiwa T; Ikeda K; Horie-Inoue K; Inoue S
    Front Cell Dev Biol; 2021; 9():641963. PubMed ID: 33996797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression.
    Ahangar Davoodi N; Najafi S; Naderi Ghale-Noie Z; Piranviseh A; Mollazadeh S; Ahmadi Asouri S; Asemi Z; Morshedi M; Tamehri Zadeh SS; Hamblin MR; Sheida A; Mirzaei H
    Front Cell Dev Biol; 2022; 10():1065837. PubMed ID: 36619866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small Non-Coding-RNA in Gynecological Malignancies.
    Dwivedi SKD; Rao G; Dey A; Mukherjee P; Wren JD; Bhattacharya R
    Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33802524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-Coding RNAs and Oral Cancer: Small Molecules With Big Functions.
    Erfanparast L; Taghizadieh M; Shekarchi AA
    Front Oncol; 2022; 12():914593. PubMed ID: 35898889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.